3Carbone M,Fera MT,Pennisi MG,et al.Activity of nine fluoroquinolones against strains of Bordetella bronchiseptica.Int J Antimicrob Agents,1999,12:355-358.
4Koning S,van Suijlekom-Smit LW,Nouwen JL,et al.Fusidic acid cream in the treatment of impetigo in general practice:double blind randomised placebo controlled trial.BMJ,2002,324:203-206.
5Johnston C.Topical 2% mupirocin versus 2% sodium fusidate ointment in the treatment of primary and secondary skin infections.J Am Acad Dermatol,1991,24:797-798.
6Liu Y, Geng W, Yang Y, et al. Susceptibility to and resistance determinants of fusidic acid in Staphylococcus attreus isolated from Chinese children with skin and soft tissue infections [J]. FEMS Im- munol Med Microbiol, 2012, 64 (2) : 212-218.
7Park MR, Kim DS, Kim J, et al. Anaphylaxis to topically ap- plied sodium fusidate [J]. Allergy Asthma Immunol Res, 2013, 5 (2) : 110-112.
8Kraus CN, Burnstead BW. The safety record of fusidic acid in non-US markets: a focus on skin infections [J]. Clin Infect Dis, 2011, 52 (7) : S527-S537.
9Schefer H, Simonsen L. Fusidic acid in dermatology: an updated review [J].EurJDermatol, 2010, 20 (1) : 6-15.
10Koning S, Van Suijlekom-Smit LW, Nouwen JL, et al. Fusidic acid cream in the treatment of impetigo in general practice : double blind randomised placebo controlled trial [J]. BMJ, 2002, 324 (7331) : 203-206.
